(XERS) Xeris Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xeris Pharmaceuticals | (XERS) share price targets
Complete technical analysis of Xeris Pharmaceuticals (XERS) by charts plus indicators, forecast predictions and share price targets for Xeris Pharmaceuticals (XERS)
Xeris Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Xeris Pharmaceuticals is 2711751
| Date | Daily Closing Price | Open | High | Low | Volume |
| 16 Fri Jan 2026 | 7.52 | 7.44 | 7.62 | 7.38 | 0.597 times |
| 15 Thu Jan 2026 | 7.41 | 7.56 | 7.60 | 7.36 | 0.662 times |
| 14 Wed Jan 2026 | 7.58 | 7.63 | 7.71 | 7.50 | 0.473 times |
| 13 Tue Jan 2026 | 7.71 | 7.86 | 7.91 | 7.53 | 0.817 times |
| 12 Mon Jan 2026 | 7.87 | 7.87 | 7.97 | 7.69 | 0.583 times |
| 09 Fri Jan 2026 | 7.93 | 8.24 | 8.27 | 7.81 | 1.016 times |
| 08 Thu Jan 2026 | 8.12 | 7.46 | 8.42 | 7.20 | 1.439 times |
| 07 Wed Jan 2026 | 7.21 | 7.02 | 7.37 | 6.96 | 1.747 times |
| 06 Tue Jan 2026 | 6.96 | 7.09 | 7.24 | 6.93 | 0.847 times |
| 05 Mon Jan 2026 | 7.09 | 7.33 | 7.45 | 6.88 | 1.383 times |
My analysis of stock is bullish for shortterm, and stock might move up till 7.7 or till 8.1. Use a stoploss of 7.44 and if this stock hits its stoploss, then it can fall down till 7.13
Share price targets for Xeris Pharmaceuticals (XERS)
| Target Type | Value |
| Downside Target | 6.47 |
| Downside Target | 6.71 |
| Downside Target | 6.88 |
| Downside Target | 7.20 |
| Upside Target | 7.78 |
| Upside Target | 7.97 |
| Upside Target | 8.22 |
| Upside Target | 8.35 |
| Upside Target | 8.42 |
| Upside Target | 10.03 |
| Upside Target | 10.08 |
Intraday share price targets for Xeris Pharmaceuticals (XERS)
| Target Type | Value |
| Downside Intraday Target | 7.26 |
| Downside Intraday Target | 7.01 |
| Upside Intraday Target | 7.87 |
| Upside Intraday Target | 8.23 |
| Upside Intraday Target | 7.62 |
Weekly technical analysis of Xeris Pharmaceuticals (XERS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 16 Fri Jan 2026 | 7.52 | 7.87 | 7.97 | 7.36 | 0.487 times |
| 09 Fri Jan 2026 | 7.93 | 7.33 | 8.42 | 6.88 | 1.922 times |
| 02 Fri Jan 2026 | 7.35 | 7.30 | 8.22 | 7.20 | 1.496 times |
| 26 Fri Dec 2025 | 7.37 | 7.33 | 7.53 | 7.01 | 0.725 times |
| 19 Fri Dec 2025 | 7.34 | 7.17 | 7.45 | 6.95 | 0.683 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Xeris Pharmaceuticals (XERS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 16 Fri Jan 2026 | 7.52 | 7.88 | 8.42 | 6.88 | 0.666 times |
| 31 Wed Dec 2025 | 7.85 | 7.08 | 8.22 | 6.47 | 0.845 times |
| 28 Fri Nov 2025 | 7.18 | 9.54 | 10.08 | 6.71 | 1.005 times |
| 31 Fri Oct 2025 | 9.70 | 8.06 | 10.03 | 7.78 | 1.205 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Xeris Pharmaceuticals (XERS)
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Xeris Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Xeris Pharmaceuticals in short term and the buy signal is strong.
Xeris Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Xeris Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Xeris Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.52 and Xeris Pharmaceuticals (XERS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Xeris Pharmaceuticals (XERS) stock. Volume based technical analysis of Xeris Pharmaceuticals (XERS) stock is negative.
Xeris Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Xeris Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Xeris Pharmaceuticals in short term and the buy signal is strong.
Xeris Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Xeris Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Xeris Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.52 and Xeris Pharmaceuticals (XERS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Xeris Pharmaceuticals (XERS) stock. Volume based technical analysis of Xeris Pharmaceuticals (XERS) stock is negative.
Xeris Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.